Skip to content
10-Q

Quarterly Report

MEDICINOVA, INC. MNOV

0001193125-26-224066

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 49.22M sh
Shares Diluted Q1 2026 · Mar 31, 2026 49.22M sh
Shares Diluted Q1 2026 · Mar 31, 2025 49.05M sh
Capex Q1 2026 · Mar 31, 2026 $10.83K
Capex Q1 2026 · Mar 31, 2025 $0
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.47M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$3.78M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $27.33M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $30.81M
Stockholders Equity Q1 2026 · Mar 31, 2026 $39.41M
Stockholders Equity Q1 2026 · Dec 31, 2025 $41.59M
Stockholders Equity Q1 2026 · Mar 31, 2025 $49.93M
Stockholders Equity Q1 2026 · Dec 31, 2024 $52.5M
Current Liabilities Q1 2026 · Mar 31, 2026 $3.1M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.8M
Total Liabilities Q1 2026 · Mar 31, 2026 $3.3M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.02M
Current Assets Q1 2026 · Mar 31, 2026 $28.15M
Current Assets Q1 2026 · Dec 31, 2025 $30.99M
Total Assets Q1 2026 · Mar 31, 2026 $42.7M
Total Assets Q1 2026 · Dec 31, 2025 $45.6M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.05
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.06
Eps Basic Q1 2026 · Mar 31, 2026 −$0.05
Eps Basic Q1 2026 · Mar 31, 2025 −$0.06
Sga Expense Q1 2026 · Mar 31, 2026 $1.59M
Sga Expense Q1 2026 · Mar 31, 2025 $1.36M
Rd Expense Q1 2026 · Mar 31, 2026 $1.2M
Rd Expense Q1 2026 · Mar 31, 2025 $1.7M
Net Income Q1 2026 · Mar 31, 2026 −$2.59M
Net Income Q1 2026 · Mar 31, 2025 −$2.86M
Operating Income Q1 2026 · Mar 31, 2026 −$2.84M
Operating Income Q1 2026 · Mar 31, 2025 −$3.2M
Revenue Q1 2026 · Mar 31, 2026 $186.98K